Berinert 2000 i.e. prašek in vehikel za raztopina za injiciranje Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

berinert 2000 i.e. prašek in vehikel za raztopina za injiciranje

inhibitor c1-esteraze - prašek in vehikel za raztopino za injiciranje - inhibitor c1-esteraze 2000 i.e. / 1 viala - zaviralec c1, pridobljen iz plazme

Berinert 3000 i.e. prašek in vehikel za raztopina za injiciranje Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

berinert 3000 i.e. prašek in vehikel za raztopina za injiciranje

inhibitor c1-esteraze - prašek in vehikel za raztopino za injiciranje - inhibitor c1-esteraze 3000 i.e. / 1 viala - zaviralec c1, pridobljen iz plazme

Ontilyv Європейський Союз - словенська - EMA (European Medicines Agency)

ontilyv

bial portela & companhia s.a. - opikapon - parkinsonova bolezen - anti-parkinsonska zdravila - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Amvuttra Європейський Союз - словенська - EMA (European Medicines Agency)

amvuttra

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - druga zdravila na živčnem sistemu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Omvoh Європейський Союз - словенська - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolitis, ulcerativni - imunosupresivi - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.